DBV Technologies (FRA:DBV) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 04, 2024)

View and export this data going back to 2012. Start your Free Trial

What is DBV Technologies 5-Year Yield-on-Cost %?

DBV Technologies's yield on cost for the quarter that ended in Mar. 2024 was 0.00.

The historical rank and industry rank for DBV Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:

FRA:DBV's 5-Year Yield-on-Cost % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.78
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of DBV Technologies's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, DBV Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DBV Technologies's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DBV Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where DBV Technologies's 5-Year Yield-on-Cost % falls into.

DBV Technologies 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of DBV Technologies is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

DBV Technologies (FRA:DBV) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

DBV Technologies 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of DBV Technologies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

DBV Technologies (FRA:DBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DBV Technologies SA (FRA:DBV) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

DBVT:USA 0QAJ:UK DBV:France DBV:Germany

Address

177-181 avenue Pierre Brossolette, Montrouge, FRA, 92120

Website

http://www.dbvtechnologies.com

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node in order to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.